Spine Biologics Market to Surpass USD 3.5 billion in 2033, expected to expand at a 4.2% CAGR: TMR Report

Wilmington, Delaware, United States, June 19, 2023 (GLOBE NEWSWIRE) -- The global spine biologics market is anticipated to be valued at US$ 3.5 billion by 2031, expected to incline at a CAGR of 4.2% from 2023 to 2031.

Related Keywords

Japan ,Canada ,India ,Australia ,Delaware ,United States ,China ,America ,American ,Asia Pacific ,Nikhil Sawlani ,Johnson Depuy Synthes ,Zimmer Biomet ,Transparency Market Research ,Surgery Centers ,Research Solutions ,Nuvasive Inc ,Human Research Ethics Committee ,Arthrex Inc ,Exactech Inc ,Bone Biologics Corporation ,Transparency Market Research Inc ,Medtronic ,Hippofi Inc ,Orthofix Medical Inc ,Stryker Corporation ,Spine Wave Inc ,Medtronic Plc ,Biologics Hippofi Inc ,American Association Of Neurological Surgeons ,Specific Research Solutions ,Biologics Market ,Prominent Growth ,North America ,American Association ,Neurological Surgeons ,Depuy Synthes ,Orthofix Medical ,Bone Matrix ,Market Research ,Canada Toll Free ,